Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF versus TDF in pregnant women with chronic hepatitis B and hepatitis activity during early to mid-pregnancy
ChiCTR2400093279Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir alafenamide and tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Alanine aminotransferase. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
tenofovir alafenamidetenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2400093279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093279.